nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—RALBP1—Vincristine—sarcoma	0.264	0.319	CbGbCtD
Carbamazepine—RALBP1—Doxorubicin—sarcoma	0.165	0.2	CbGbCtD
Carbamazepine—UGT2B7—Epirubicin—sarcoma	0.0619	0.0749	CbGbCtD
Carbamazepine—CYP2B6—Thiotepa—sarcoma	0.0594	0.072	CbGbCtD
Carbamazepine—ABCC2—Vincristine—sarcoma	0.0277	0.0335	CbGbCtD
Carbamazepine—ABCC2—Etoposide—sarcoma	0.0253	0.0307	CbGbCtD
Carbamazepine—CYP1A2—Dacarbazine—sarcoma	0.0193	0.0234	CbGbCtD
Carbamazepine—CYP3A7—Vincristine—sarcoma	0.0185	0.0224	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0185	0.0224	CbGbCtD
Carbamazepine—CYP3A4—Thiotepa—sarcoma	0.0183	0.0221	CbGbCtD
Carbamazepine—ABCC2—Doxorubicin—sarcoma	0.0173	0.0209	CbGbCtD
Carbamazepine—ABCB1—Dactinomycin—sarcoma	0.0146	0.0177	CbGbCtD
Carbamazepine—CYP3A5—Vincristine—sarcoma	0.0139	0.0168	CbGbCtD
Carbamazepine—ABCB1—Mitoxantrone—sarcoma	0.0131	0.0159	CbGbCtD
Carbamazepine—CYP3A5—Etoposide—sarcoma	0.0127	0.0154	CbGbCtD
Carbamazepine—CYP2C8—Etoposide—sarcoma	0.0122	0.0148	CbGbCtD
Carbamazepine—CYP2B6—Doxorubicin—sarcoma	0.011	0.0133	CbGbCtD
Carbamazepine—CYP1A2—Etoposide—sarcoma	0.00945	0.0114	CbGbCtD
Carbamazepine—ABCB1—Vincristine—sarcoma	0.00901	0.0109	CbGbCtD
Carbamazepine—ABCB1—Etoposide—sarcoma	0.00826	0.01	CbGbCtD
Carbamazepine—CYP3A4—Mitoxantrone—sarcoma	0.00785	0.0095	CbGbCtD
Carbamazepine—ABCB1—Doxorubicin—sarcoma	0.00563	0.00682	CbGbCtD
Carbamazepine—CYP3A4—Vincristine—sarcoma	0.0054	0.00654	CbGbCtD
Carbamazepine—CYP3A4—Etoposide—sarcoma	0.00495	0.00599	CbGbCtD
Carbamazepine—CYP3A4—Doxorubicin—sarcoma	0.00338	0.00409	CbGbCtD
Carbamazepine—RALBP1—myometrium—sarcoma	0.000579	0.0516	CbGeAlD
Carbamazepine—RALBP1—seminal vesicle—sarcoma	0.000523	0.0466	CbGeAlD
Carbamazepine—RALBP1—hematopoietic system—sarcoma	0.000497	0.0443	CbGeAlD
Carbamazepine—RALBP1—smooth muscle tissue—sarcoma	0.000438	0.039	CbGeAlD
Carbamazepine—RALBP1—cardiac atrium—sarcoma	0.000377	0.0336	CbGeAlD
Carbamazepine—RALBP1—uterus—sarcoma	0.000375	0.0334	CbGeAlD
Carbamazepine—SCN9A—tendon—sarcoma	0.00034	0.0303	CbGeAlD
Carbamazepine—RALBP1—tendon—sarcoma	0.000329	0.0293	CbGeAlD
Carbamazepine—CYP2C8—mammary gland—sarcoma	0.000328	0.0292	CbGeAlD
Carbamazepine—RALBP1—bone marrow—sarcoma	0.000318	0.0284	CbGeAlD
Carbamazepine—SCN4A—tendon—sarcoma	0.000303	0.027	CbGeAlD
Carbamazepine—CYP2C9—mammary gland—sarcoma	0.000291	0.026	CbGeAlD
Carbamazepine—SCN9A—testis—sarcoma	0.000281	0.0251	CbGeAlD
Carbamazepine—UGT2B7—testis—sarcoma	0.000272	0.0243	CbGeAlD
Carbamazepine—RALBP1—testis—sarcoma	0.000272	0.0243	CbGeAlD
Carbamazepine—SCN5A—cardiac atrium—sarcoma	0.00027	0.024	CbGeAlD
Carbamazepine—CYP3A7—liver—sarcoma	0.000266	0.0237	CbGeAlD
Carbamazepine—RALBP1—liver—sarcoma	0.000257	0.0229	CbGeAlD
Carbamazepine—UGT2B7—liver—sarcoma	0.000257	0.0229	CbGeAlD
Carbamazepine—SCN4A—testis—sarcoma	0.000251	0.0224	CbGeAlD
Carbamazepine—CYP2C19—hematopoietic system—sarcoma	0.000229	0.0204	CbGeAlD
Carbamazepine—CYP3A7-CYP3A51P—liver—sarcoma	0.000226	0.0201	CbGeAlD
Carbamazepine—SCN9A—lymph node—sarcoma	0.000204	0.0182	CbGeAlD
Carbamazepine—CYP2C8—hematopoietic system—sarcoma	0.0002	0.0178	CbGeAlD
Carbamazepine—RALBP1—lymph node—sarcoma	0.000197	0.0176	CbGeAlD
Carbamazepine—RALBP1—Regulation of CDC42 activity—PLCG1—sarcoma	0.000191	0.0755	CbGpPWpGaD
Carbamazepine—CYP1A2—hematopoietic system—sarcoma	0.000187	0.0167	CbGeAlD
Carbamazepine—CYP3A5—hematopoietic system—sarcoma	0.00018	0.0161	CbGeAlD
Carbamazepine—CYP2B6—hematopoietic system—sarcoma	0.000179	0.016	CbGeAlD
Carbamazepine—CYP2C9—hematopoietic system—sarcoma	0.000178	0.0158	CbGeAlD
Carbamazepine—ABCC2—tendon—sarcoma	0.000176	0.0157	CbGeAlD
Carbamazepine—CYP2B6—skin of body—sarcoma	0.000156	0.0139	CbGeAlD
Carbamazepine—ABCC2—testis—sarcoma	0.000146	0.013	CbGeAlD
Carbamazepine—ABCC2—liver—sarcoma	0.000138	0.0123	CbGeAlD
Carbamazepine—CYP3A4—hematopoietic system—sarcoma	0.000135	0.0121	CbGeAlD
Carbamazepine—Pollakiuria—Epirubicin—sarcoma	0.000132	0.000823	CcSEcCtD
Carbamazepine—Hypersensitivity—Vincristine—sarcoma	0.000132	0.000822	CcSEcCtD
Carbamazepine—Eosinophilia—Doxorubicin—sarcoma	0.000131	0.000816	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Epirubicin—sarcoma	0.00013	0.000813	CcSEcCtD
Carbamazepine—Paraesthesia—Etoposide—sarcoma	0.00013	0.000811	CcSEcCtD
Carbamazepine—Weight increased—Epirubicin—sarcoma	0.00013	0.000811	CcSEcCtD
Carbamazepine—Pancreatitis—Doxorubicin—sarcoma	0.00013	0.000808	CcSEcCtD
Carbamazepine—Dyspnoea—Etoposide—sarcoma	0.000129	0.000806	CcSEcCtD
Carbamazepine—Hyperglycaemia—Epirubicin—sarcoma	0.000129	0.000803	CcSEcCtD
Carbamazepine—Somnolence—Etoposide—sarcoma	0.000129	0.000803	CcSEcCtD
Carbamazepine—Hypersensitivity—Mitoxantrone—sarcoma	0.000128	0.0008	CcSEcCtD
Carbamazepine—Asthenia—Vincristine—sarcoma	0.000128	0.0008	CcSEcCtD
Carbamazepine—Vomiting—Thiotepa—sarcoma	0.000128	0.0008	CcSEcCtD
Carbamazepine—Pneumonia—Epirubicin—sarcoma	0.000128	0.000799	CcSEcCtD
Carbamazepine—Drowsiness—Epirubicin—sarcoma	0.000127	0.000794	CcSEcCtD
Carbamazepine—Infestation NOS—Epirubicin—sarcoma	0.000127	0.000794	CcSEcCtD
Carbamazepine—Infestation—Epirubicin—sarcoma	0.000127	0.000794	CcSEcCtD
Carbamazepine—Vomiting—Dactinomycin—sarcoma	0.000127	0.000794	CcSEcCtD
Carbamazepine—Rash—Thiotepa—sarcoma	0.000127	0.000793	CcSEcCtD
Carbamazepine—Bronchitis—Doxorubicin—sarcoma	0.000127	0.000793	CcSEcCtD
Carbamazepine—Dermatitis—Thiotepa—sarcoma	0.000127	0.000792	CcSEcCtD
Carbamazepine—RALBP1—RalA downstream regulated genes—NRAS—sarcoma	0.000127	0.0502	CbGpPWpGaD
Carbamazepine—Headache—Thiotepa—sarcoma	0.000126	0.000788	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000126	0.000787	CcSEcCtD
Carbamazepine—Rash—Dactinomycin—sarcoma	0.000126	0.000787	CcSEcCtD
Carbamazepine—CYP2B6—lymphoid tissue—sarcoma	0.000126	0.0112	CbGeAlD
Carbamazepine—Decreased appetite—Etoposide—sarcoma	0.000126	0.000786	CcSEcCtD
Carbamazepine—Pancytopenia—Doxorubicin—sarcoma	0.000126	0.000783	CcSEcCtD
Carbamazepine—Renal failure—Epirubicin—sarcoma	0.000125	0.000781	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Etoposide—sarcoma	0.000125	0.00078	CcSEcCtD
Carbamazepine—Asthenia—Mitoxantrone—sarcoma	0.000125	0.000779	CcSEcCtD
Carbamazepine—Fatigue—Etoposide—sarcoma	0.000125	0.000779	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Epirubicin—sarcoma	0.000125	0.000779	CcSEcCtD
Carbamazepine—Stomatitis—Epirubicin—sarcoma	0.000124	0.000774	CcSEcCtD
Carbamazepine—Jaundice—Epirubicin—sarcoma	0.000124	0.000774	CcSEcCtD
Carbamazepine—Pain—Etoposide—sarcoma	0.000124	0.000773	CcSEcCtD
Carbamazepine—Constipation—Etoposide—sarcoma	0.000124	0.000773	CcSEcCtD
Carbamazepine—Conjunctivitis—Epirubicin—sarcoma	0.000124	0.000772	CcSEcCtD
Carbamazepine—Urinary tract infection—Epirubicin—sarcoma	0.000124	0.000772	CcSEcCtD
Carbamazepine—Diarrhoea—Vincristine—sarcoma	0.000122	0.000763	CcSEcCtD
Carbamazepine—Pollakiuria—Doxorubicin—sarcoma	0.000122	0.000761	CcSEcCtD
Carbamazepine—Haematuria—Epirubicin—sarcoma	0.000122	0.000757	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000121	0.000752	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Epirubicin—sarcoma	0.000121	0.000751	CcSEcCtD
Carbamazepine—Weight increased—Doxorubicin—sarcoma	0.00012	0.00075	CcSEcCtD
Carbamazepine—Nausea—Thiotepa—sarcoma	0.00012	0.000747	CcSEcCtD
Carbamazepine—Sinusitis—Epirubicin—sarcoma	0.00012	0.000745	CcSEcCtD
Carbamazepine—Feeling abnormal—Etoposide—sarcoma	0.000119	0.000745	CcSEcCtD
Carbamazepine—Hyperglycaemia—Doxorubicin—sarcoma	0.000119	0.000743	CcSEcCtD
Carbamazepine—Diarrhoea—Mitoxantrone—sarcoma	0.000119	0.000743	CcSEcCtD
Carbamazepine—Nausea—Dactinomycin—sarcoma	0.000119	0.000742	CcSEcCtD
Carbamazepine—Agranulocytosis—Epirubicin—sarcoma	0.000119	0.000741	CcSEcCtD
Carbamazepine—CYP2C19—liver—sarcoma	0.000119	0.0106	CbGeAlD
Carbamazepine—Pneumonia—Doxorubicin—sarcoma	0.000119	0.000739	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Etoposide—sarcoma	0.000119	0.000739	CcSEcCtD
Carbamazepine—Dizziness—Vincristine—sarcoma	0.000118	0.000738	CcSEcCtD
Carbamazepine—Infestation—Doxorubicin—sarcoma	0.000118	0.000735	CcSEcCtD
Carbamazepine—Drowsiness—Doxorubicin—sarcoma	0.000118	0.000735	CcSEcCtD
Carbamazepine—Infestation NOS—Doxorubicin—sarcoma	0.000118	0.000735	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000117	0.000729	CcSEcCtD
Carbamazepine—Bradycardia—Epirubicin—sarcoma	0.000116	0.000726	CcSEcCtD
Carbamazepine—Renal failure—Doxorubicin—sarcoma	0.000116	0.000722	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000116	0.00072	CcSEcCtD
Carbamazepine—Urticaria—Etoposide—sarcoma	0.000115	0.000718	CcSEcCtD
Carbamazepine—Jaundice—Doxorubicin—sarcoma	0.000115	0.000716	CcSEcCtD
Carbamazepine—Stomatitis—Doxorubicin—sarcoma	0.000115	0.000716	CcSEcCtD
Carbamazepine—Rhinitis—Epirubicin—sarcoma	0.000115	0.000715	CcSEcCtD
Carbamazepine—Body temperature increased—Etoposide—sarcoma	0.000115	0.000714	CcSEcCtD
Carbamazepine—Abdominal pain—Etoposide—sarcoma	0.000115	0.000714	CcSEcCtD
Carbamazepine—Conjunctivitis—Doxorubicin—sarcoma	0.000115	0.000714	CcSEcCtD
Carbamazepine—Urinary tract infection—Doxorubicin—sarcoma	0.000115	0.000714	CcSEcCtD
Carbamazepine—Hepatitis—Epirubicin—sarcoma	0.000114	0.000713	CcSEcCtD
Carbamazepine—Vomiting—Vincristine—sarcoma	0.000114	0.000709	CcSEcCtD
Carbamazepine—Pharyngitis—Epirubicin—sarcoma	0.000114	0.000708	CcSEcCtD
Carbamazepine—Urinary tract disorder—Epirubicin—sarcoma	0.000113	0.000704	CcSEcCtD
Carbamazepine—Rash—Vincristine—sarcoma	0.000113	0.000703	CcSEcCtD
Carbamazepine—Dermatitis—Vincristine—sarcoma	0.000113	0.000703	CcSEcCtD
Carbamazepine—Oedema peripheral—Epirubicin—sarcoma	0.000113	0.000702	CcSEcCtD
Carbamazepine—Haematuria—Doxorubicin—sarcoma	0.000112	0.000701	CcSEcCtD
Carbamazepine—Connective tissue disorder—Epirubicin—sarcoma	0.000112	0.000701	CcSEcCtD
Carbamazepine—Urethral disorder—Epirubicin—sarcoma	0.000112	0.000699	CcSEcCtD
Carbamazepine—Headache—Vincristine—sarcoma	0.000112	0.000699	CcSEcCtD
Carbamazepine—ABCB1—myometrium—sarcoma	0.000112	0.00995	CbGeAlD
Carbamazepine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000112	0.000695	CcSEcCtD
Carbamazepine—Vomiting—Mitoxantrone—sarcoma	0.000111	0.000691	CcSEcCtD
Carbamazepine—Sinusitis—Doxorubicin—sarcoma	0.000111	0.000689	CcSEcCtD
Carbamazepine—Agranulocytosis—Doxorubicin—sarcoma	0.00011	0.000686	CcSEcCtD
Carbamazepine—Rash—Mitoxantrone—sarcoma	0.00011	0.000685	CcSEcCtD
Carbamazepine—Dermatitis—Mitoxantrone—sarcoma	0.00011	0.000684	CcSEcCtD
Carbamazepine—CYP2C8—testis—sarcoma	0.00011	0.00976	CbGeAlD
Carbamazepine—Headache—Mitoxantrone—sarcoma	0.000109	0.000681	CcSEcCtD
Carbamazepine—RALBP1—RalA downstream regulated genes—KRAS—sarcoma	0.000109	0.0432	CbGpPWpGaD
Carbamazepine—Erythema multiforme—Epirubicin—sarcoma	0.000108	0.000674	CcSEcCtD
Carbamazepine—Bradycardia—Doxorubicin—sarcoma	0.000108	0.000672	CcSEcCtD
Carbamazepine—ABCB1—embryo—sarcoma	0.000107	0.00957	CbGeAlD
Carbamazepine—Eye disorder—Epirubicin—sarcoma	0.000107	0.000666	CcSEcCtD
Carbamazepine—Hypersensitivity—Etoposide—sarcoma	0.000107	0.000666	CcSEcCtD
Carbamazepine—Tinnitus—Epirubicin—sarcoma	0.000107	0.000665	CcSEcCtD
Carbamazepine—Nausea—Vincristine—sarcoma	0.000106	0.000663	CcSEcCtD
Carbamazepine—Flushing—Epirubicin—sarcoma	0.000106	0.000662	CcSEcCtD
Carbamazepine—Cardiac disorder—Epirubicin—sarcoma	0.000106	0.000662	CcSEcCtD
Carbamazepine—Rhinitis—Doxorubicin—sarcoma	0.000106	0.000661	CcSEcCtD
Carbamazepine—ABCC2—lymph node—sarcoma	0.000106	0.00943	CbGeAlD
Carbamazepine—Hepatitis—Doxorubicin—sarcoma	0.000106	0.00066	CcSEcCtD
Carbamazepine—Pharyngitis—Doxorubicin—sarcoma	0.000105	0.000655	CcSEcCtD
Carbamazepine—Urinary tract disorder—Doxorubicin—sarcoma	0.000105	0.000651	CcSEcCtD
Carbamazepine—Oedema peripheral—Doxorubicin—sarcoma	0.000104	0.00065	CcSEcCtD
Carbamazepine—Asthenia—Etoposide—sarcoma	0.000104	0.000648	CcSEcCtD
Carbamazepine—Connective tissue disorder—Doxorubicin—sarcoma	0.000104	0.000648	CcSEcCtD
Carbamazepine—Angiopathy—Epirubicin—sarcoma	0.000104	0.000647	CcSEcCtD
Carbamazepine—Urethral disorder—Doxorubicin—sarcoma	0.000104	0.000647	CcSEcCtD
Carbamazepine—CYP2C8—liver—sarcoma	0.000104	0.00923	CbGeAlD
Carbamazepine—Nausea—Mitoxantrone—sarcoma	0.000104	0.000645	CcSEcCtD
Carbamazepine—Immune system disorder—Epirubicin—sarcoma	0.000103	0.000644	CcSEcCtD
Carbamazepine—Mediastinal disorder—Epirubicin—sarcoma	0.000103	0.000643	CcSEcCtD
Carbamazepine—Chills—Epirubicin—sarcoma	0.000103	0.00064	CcSEcCtD
Carbamazepine—Pruritus—Etoposide—sarcoma	0.000103	0.000639	CcSEcCtD
Carbamazepine—Arrhythmia—Epirubicin—sarcoma	0.000102	0.000637	CcSEcCtD
Carbamazepine—Alopecia—Epirubicin—sarcoma	0.000101	0.00063	CcSEcCtD
Carbamazepine—ABCB1—seminal vesicle—sarcoma	0.000101	0.00899	CbGeAlD
Carbamazepine—Mental disorder—Epirubicin—sarcoma	0.0001	0.000625	CcSEcCtD
Carbamazepine—Erythema multiforme—Doxorubicin—sarcoma	0.0001	0.000624	CcSEcCtD
Carbamazepine—Erythema—Epirubicin—sarcoma	9.96e-05	0.000621	CcSEcCtD
Carbamazepine—Malnutrition—Epirubicin—sarcoma	9.96e-05	0.000621	CcSEcCtD
Carbamazepine—Diarrhoea—Etoposide—sarcoma	9.92e-05	0.000618	CcSEcCtD
Carbamazepine—Eye disorder—Doxorubicin—sarcoma	9.89e-05	0.000616	CcSEcCtD
Carbamazepine—Tinnitus—Doxorubicin—sarcoma	9.87e-05	0.000615	CcSEcCtD
Carbamazepine—CYP2B6—testis—sarcoma	9.83e-05	0.00876	CbGeAlD
Carbamazepine—Cardiac disorder—Doxorubicin—sarcoma	9.82e-05	0.000612	CcSEcCtD
Carbamazepine—Flushing—Doxorubicin—sarcoma	9.82e-05	0.000612	CcSEcCtD
Carbamazepine—Tension—Epirubicin—sarcoma	9.77e-05	0.000609	CcSEcCtD
Carbamazepine—Dysgeusia—Epirubicin—sarcoma	9.75e-05	0.000608	CcSEcCtD
Carbamazepine—CYP1A2—liver—sarcoma	9.69e-05	0.00864	CbGeAlD
Carbamazepine—Nervousness—Epirubicin—sarcoma	9.67e-05	0.000603	CcSEcCtD
Carbamazepine—Back pain—Epirubicin—sarcoma	9.63e-05	0.0006	CcSEcCtD
Carbamazepine—Angiopathy—Doxorubicin—sarcoma	9.6e-05	0.000599	CcSEcCtD
Carbamazepine—Dizziness—Etoposide—sarcoma	9.59e-05	0.000598	CcSEcCtD
Carbamazepine—ABCB1—hematopoietic system—sarcoma	9.58e-05	0.00854	CbGeAlD
Carbamazepine—Muscle spasms—Epirubicin—sarcoma	9.57e-05	0.000597	CcSEcCtD
Carbamazepine—Immune system disorder—Doxorubicin—sarcoma	9.56e-05	0.000596	CcSEcCtD
Carbamazepine—Mediastinal disorder—Doxorubicin—sarcoma	9.54e-05	0.000595	CcSEcCtD
Carbamazepine—Chills—Doxorubicin—sarcoma	9.5e-05	0.000592	CcSEcCtD
Carbamazepine—Arrhythmia—Doxorubicin—sarcoma	9.46e-05	0.000589	CcSEcCtD
Carbamazepine—Vision blurred—Epirubicin—sarcoma	9.39e-05	0.000585	CcSEcCtD
Carbamazepine—Alopecia—Doxorubicin—sarcoma	9.35e-05	0.000583	CcSEcCtD
Carbamazepine—CYP3A5—liver—sarcoma	9.35e-05	0.00833	CbGeAlD
Carbamazepine—CYP2B6—liver—sarcoma	9.29e-05	0.00828	CbGeAlD
Carbamazepine—Mental disorder—Doxorubicin—sarcoma	9.27e-05	0.000578	CcSEcCtD
Carbamazepine—RALBP1—RalA downstream regulated genes—HRAS—sarcoma	9.27e-05	0.0367	CbGpPWpGaD
Carbamazepine—Vomiting—Etoposide—sarcoma	9.22e-05	0.000575	CcSEcCtD
Carbamazepine—Malnutrition—Doxorubicin—sarcoma	9.21e-05	0.000574	CcSEcCtD
Carbamazepine—Erythema—Doxorubicin—sarcoma	9.21e-05	0.000574	CcSEcCtD
Carbamazepine—Anaemia—Epirubicin—sarcoma	9.2e-05	0.000574	CcSEcCtD
Carbamazepine—CYP2C9—liver—sarcoma	9.2e-05	0.0082	CbGeAlD
Carbamazepine—Agitation—Epirubicin—sarcoma	9.15e-05	0.00057	CcSEcCtD
Carbamazepine—Rash—Etoposide—sarcoma	9.14e-05	0.00057	CcSEcCtD
Carbamazepine—Dermatitis—Etoposide—sarcoma	9.13e-05	0.000569	CcSEcCtD
Carbamazepine—Headache—Etoposide—sarcoma	9.08e-05	0.000566	CcSEcCtD
Carbamazepine—Tension—Doxorubicin—sarcoma	9.04e-05	0.000564	CcSEcCtD
Carbamazepine—Dysgeusia—Doxorubicin—sarcoma	9.02e-05	0.000562	CcSEcCtD
Carbamazepine—Nervousness—Doxorubicin—sarcoma	8.95e-05	0.000558	CcSEcCtD
Carbamazepine—Vertigo—Epirubicin—sarcoma	8.95e-05	0.000558	CcSEcCtD
Carbamazepine—Syncope—Epirubicin—sarcoma	8.93e-05	0.000557	CcSEcCtD
Carbamazepine—Leukopenia—Epirubicin—sarcoma	8.91e-05	0.000556	CcSEcCtD
Carbamazepine—Back pain—Doxorubicin—sarcoma	8.91e-05	0.000555	CcSEcCtD
Carbamazepine—Muscle spasms—Doxorubicin—sarcoma	8.86e-05	0.000552	CcSEcCtD
Carbamazepine—Loss of consciousness—Epirubicin—sarcoma	8.75e-05	0.000545	CcSEcCtD
Carbamazepine—Vision blurred—Doxorubicin—sarcoma	8.68e-05	0.000541	CcSEcCtD
Carbamazepine—Convulsion—Epirubicin—sarcoma	8.63e-05	0.000538	CcSEcCtD
Carbamazepine—Nausea—Etoposide—sarcoma	8.61e-05	0.000537	CcSEcCtD
Carbamazepine—Hypertension—Epirubicin—sarcoma	8.6e-05	0.000536	CcSEcCtD
Carbamazepine—SCN9A—L1CAM interactions—EZR—sarcoma	8.59e-05	0.034	CbGpPWpGaD
Carbamazepine—Anaemia—Doxorubicin—sarcoma	8.52e-05	0.000531	CcSEcCtD
Carbamazepine—Chest pain—Epirubicin—sarcoma	8.48e-05	0.000528	CcSEcCtD
Carbamazepine—Myalgia—Epirubicin—sarcoma	8.48e-05	0.000528	CcSEcCtD
Carbamazepine—Arthralgia—Epirubicin—sarcoma	8.48e-05	0.000528	CcSEcCtD
Carbamazepine—Agitation—Doxorubicin—sarcoma	8.47e-05	0.000528	CcSEcCtD
Carbamazepine—Anxiety—Epirubicin—sarcoma	8.45e-05	0.000527	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	8.42e-05	0.000525	CcSEcCtD
Carbamazepine—Dry mouth—Epirubicin—sarcoma	8.29e-05	0.000517	CcSEcCtD
Carbamazepine—Vertigo—Doxorubicin—sarcoma	8.28e-05	0.000516	CcSEcCtD
Carbamazepine—Syncope—Doxorubicin—sarcoma	8.26e-05	0.000515	CcSEcCtD
Carbamazepine—Leukopenia—Doxorubicin—sarcoma	8.25e-05	0.000514	CcSEcCtD
Carbamazepine—Confusional state—Epirubicin—sarcoma	8.2e-05	0.000511	CcSEcCtD
Carbamazepine—Anaphylactic shock—Epirubicin—sarcoma	8.13e-05	0.000507	CcSEcCtD
Carbamazepine—Oedema—Epirubicin—sarcoma	8.13e-05	0.000507	CcSEcCtD
Carbamazepine—Loss of consciousness—Doxorubicin—sarcoma	8.1e-05	0.000505	CcSEcCtD
Carbamazepine—Infection—Epirubicin—sarcoma	8.07e-05	0.000503	CcSEcCtD
Carbamazepine—Shock—Epirubicin—sarcoma	8e-05	0.000498	CcSEcCtD
Carbamazepine—Convulsion—Doxorubicin—sarcoma	7.98e-05	0.000498	CcSEcCtD
Carbamazepine—Nervous system disorder—Epirubicin—sarcoma	7.97e-05	0.000497	CcSEcCtD
Carbamazepine—Thrombocytopenia—Epirubicin—sarcoma	7.96e-05	0.000496	CcSEcCtD
Carbamazepine—Hypertension—Doxorubicin—sarcoma	7.96e-05	0.000496	CcSEcCtD
Carbamazepine—Tachycardia—Epirubicin—sarcoma	7.93e-05	0.000494	CcSEcCtD
Carbamazepine—Skin disorder—Epirubicin—sarcoma	7.89e-05	0.000492	CcSEcCtD
Carbamazepine—SCN4A—L1CAM interactions—EZR—sarcoma	7.89e-05	0.0313	CbGpPWpGaD
Carbamazepine—Hyperhidrosis—Epirubicin—sarcoma	7.86e-05	0.00049	CcSEcCtD
Carbamazepine—Chest pain—Doxorubicin—sarcoma	7.84e-05	0.000489	CcSEcCtD
Carbamazepine—Myalgia—Doxorubicin—sarcoma	7.84e-05	0.000489	CcSEcCtD
Carbamazepine—Arthralgia—Doxorubicin—sarcoma	7.84e-05	0.000489	CcSEcCtD
Carbamazepine—Anxiety—Doxorubicin—sarcoma	7.82e-05	0.000487	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	7.79e-05	0.000486	CcSEcCtD
Carbamazepine—Anorexia—Epirubicin—sarcoma	7.75e-05	0.000483	CcSEcCtD
Carbamazepine—Dry mouth—Doxorubicin—sarcoma	7.67e-05	0.000478	CcSEcCtD
Carbamazepine—Hypotension—Epirubicin—sarcoma	7.59e-05	0.000473	CcSEcCtD
Carbamazepine—Confusional state—Doxorubicin—sarcoma	7.58e-05	0.000473	CcSEcCtD
Carbamazepine—Oedema—Doxorubicin—sarcoma	7.52e-05	0.000469	CcSEcCtD
Carbamazepine—Anaphylactic shock—Doxorubicin—sarcoma	7.52e-05	0.000469	CcSEcCtD
Carbamazepine—Infection—Doxorubicin—sarcoma	7.47e-05	0.000466	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Epirubicin—sarcoma	7.4e-05	0.000461	CcSEcCtD
Carbamazepine—Shock—Doxorubicin—sarcoma	7.4e-05	0.000461	CcSEcCtD
Carbamazepine—Nervous system disorder—Doxorubicin—sarcoma	7.38e-05	0.00046	CcSEcCtD
Carbamazepine—Thrombocytopenia—Doxorubicin—sarcoma	7.36e-05	0.000459	CcSEcCtD
Carbamazepine—Insomnia—Epirubicin—sarcoma	7.35e-05	0.000458	CcSEcCtD
Carbamazepine—Tachycardia—Doxorubicin—sarcoma	7.34e-05	0.000457	CcSEcCtD
Carbamazepine—Skin disorder—Doxorubicin—sarcoma	7.3e-05	0.000455	CcSEcCtD
Carbamazepine—Paraesthesia—Epirubicin—sarcoma	7.3e-05	0.000455	CcSEcCtD
Carbamazepine—Hyperhidrosis—Doxorubicin—sarcoma	7.27e-05	0.000453	CcSEcCtD
Carbamazepine—Dyspnoea—Epirubicin—sarcoma	7.25e-05	0.000452	CcSEcCtD
Carbamazepine—ABCB1—uterus—sarcoma	7.24e-05	0.00645	CbGeAlD
Carbamazepine—Somnolence—Epirubicin—sarcoma	7.23e-05	0.00045	CcSEcCtD
Carbamazepine—Anorexia—Doxorubicin—sarcoma	7.17e-05	0.000447	CcSEcCtD
Carbamazepine—Dyspepsia—Epirubicin—sarcoma	7.15e-05	0.000446	CcSEcCtD
Carbamazepine—Decreased appetite—Epirubicin—sarcoma	7.07e-05	0.00044	CcSEcCtD
Carbamazepine—Hypotension—Doxorubicin—sarcoma	7.03e-05	0.000438	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Epirubicin—sarcoma	7.02e-05	0.000437	CcSEcCtD
Carbamazepine—CYP3A4—liver—sarcoma	7.01e-05	0.00625	CbGeAlD
Carbamazepine—Fatigue—Epirubicin—sarcoma	7.01e-05	0.000437	CcSEcCtD
Carbamazepine—Pain—Epirubicin—sarcoma	6.95e-05	0.000433	CcSEcCtD
Carbamazepine—Constipation—Epirubicin—sarcoma	6.95e-05	0.000433	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Doxorubicin—sarcoma	6.85e-05	0.000427	CcSEcCtD
Carbamazepine—Insomnia—Doxorubicin—sarcoma	6.8e-05	0.000424	CcSEcCtD
Carbamazepine—Paraesthesia—Doxorubicin—sarcoma	6.75e-05	0.000421	CcSEcCtD
Carbamazepine—ABCB1—lymphoid tissue—sarcoma	6.75e-05	0.00601	CbGeAlD
Carbamazepine—Dyspnoea—Doxorubicin—sarcoma	6.7e-05	0.000418	CcSEcCtD
Carbamazepine—Feeling abnormal—Epirubicin—sarcoma	6.7e-05	0.000417	CcSEcCtD
Carbamazepine—Somnolence—Doxorubicin—sarcoma	6.69e-05	0.000417	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Epirubicin—sarcoma	6.65e-05	0.000414	CcSEcCtD
Carbamazepine—Dyspepsia—Doxorubicin—sarcoma	6.62e-05	0.000413	CcSEcCtD
Carbamazepine—Decreased appetite—Doxorubicin—sarcoma	6.54e-05	0.000407	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Doxorubicin—sarcoma	6.49e-05	0.000405	CcSEcCtD
Carbamazepine—Fatigue—Doxorubicin—sarcoma	6.48e-05	0.000404	CcSEcCtD
Carbamazepine—Urticaria—Epirubicin—sarcoma	6.46e-05	0.000402	CcSEcCtD
Carbamazepine—Pain—Doxorubicin—sarcoma	6.43e-05	0.000401	CcSEcCtD
Carbamazepine—Constipation—Doxorubicin—sarcoma	6.43e-05	0.000401	CcSEcCtD
Carbamazepine—Abdominal pain—Epirubicin—sarcoma	6.43e-05	0.0004	CcSEcCtD
Carbamazepine—Body temperature increased—Epirubicin—sarcoma	6.43e-05	0.0004	CcSEcCtD
Carbamazepine—Feeling abnormal—Doxorubicin—sarcoma	6.2e-05	0.000386	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Doxorubicin—sarcoma	6.15e-05	0.000383	CcSEcCtD
Carbamazepine—ABCB1—bone marrow—sarcoma	6.14e-05	0.00548	CbGeAlD
Carbamazepine—Hypersensitivity—Epirubicin—sarcoma	5.99e-05	0.000373	CcSEcCtD
Carbamazepine—Urticaria—Doxorubicin—sarcoma	5.97e-05	0.000372	CcSEcCtD
Carbamazepine—Body temperature increased—Doxorubicin—sarcoma	5.94e-05	0.00037	CcSEcCtD
Carbamazepine—Abdominal pain—Doxorubicin—sarcoma	5.94e-05	0.00037	CcSEcCtD
Carbamazepine—Asthenia—Epirubicin—sarcoma	5.83e-05	0.000363	CcSEcCtD
Carbamazepine—Pruritus—Epirubicin—sarcoma	5.75e-05	0.000358	CcSEcCtD
Carbamazepine—Diarrhoea—Epirubicin—sarcoma	5.56e-05	0.000347	CcSEcCtD
Carbamazepine—Hypersensitivity—Doxorubicin—sarcoma	5.54e-05	0.000345	CcSEcCtD
Carbamazepine—Asthenia—Doxorubicin—sarcoma	5.4e-05	0.000336	CcSEcCtD
Carbamazepine—Dizziness—Epirubicin—sarcoma	5.37e-05	0.000335	CcSEcCtD
Carbamazepine—SCN5A—L1CAM interactions—EZR—sarcoma	5.35e-05	0.0212	CbGpPWpGaD
Carbamazepine—Pruritus—Doxorubicin—sarcoma	5.32e-05	0.000332	CcSEcCtD
Carbamazepine—ABCB1—testis—sarcoma	5.25e-05	0.00468	CbGeAlD
Carbamazepine—Vomiting—Epirubicin—sarcoma	5.17e-05	0.000322	CcSEcCtD
Carbamazepine—Diarrhoea—Doxorubicin—sarcoma	5.15e-05	0.000321	CcSEcCtD
Carbamazepine—Rash—Epirubicin—sarcoma	5.12e-05	0.000319	CcSEcCtD
Carbamazepine—Dermatitis—Epirubicin—sarcoma	5.12e-05	0.000319	CcSEcCtD
Carbamazepine—Headache—Epirubicin—sarcoma	5.09e-05	0.000317	CcSEcCtD
Carbamazepine—Dizziness—Doxorubicin—sarcoma	4.97e-05	0.00031	CcSEcCtD
Carbamazepine—ABCB1—liver—sarcoma	4.96e-05	0.00442	CbGeAlD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—PLCG1—sarcoma	4.94e-05	0.0196	CbGpPWpGaD
Carbamazepine—Nausea—Epirubicin—sarcoma	4.83e-05	0.000301	CcSEcCtD
Carbamazepine—Vomiting—Doxorubicin—sarcoma	4.78e-05	0.000298	CcSEcCtD
Carbamazepine—SCN5A—Cardiac Progenitor Differentiation—CXCR4—sarcoma	4.77e-05	0.0189	CbGpPWpGaD
Carbamazepine—Rash—Doxorubicin—sarcoma	4.74e-05	0.000296	CcSEcCtD
Carbamazepine—Dermatitis—Doxorubicin—sarcoma	4.74e-05	0.000295	CcSEcCtD
Carbamazepine—Headache—Doxorubicin—sarcoma	4.71e-05	0.000294	CcSEcCtD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—ATF1—sarcoma	4.7e-05	0.0186	CbGpPWpGaD
Carbamazepine—Nausea—Doxorubicin—sarcoma	4.47e-05	0.000278	CcSEcCtD
Carbamazepine—ABCB1—lymph node—sarcoma	3.81e-05	0.00339	CbGeAlD
Carbamazepine—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	3.71e-05	0.0147	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—FOXO1—sarcoma	3.51e-05	0.0139	CbGpPWpGaD
Carbamazepine—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—sarcoma	3.46e-05	0.0137	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—EZR—sarcoma	3.25e-05	0.0129	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—MYOG—sarcoma	3.06e-05	0.0121	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—EZR—sarcoma	2.98e-05	0.0118	CbGpPWpGaD
Carbamazepine—SCN5A—Cardiac Progenitor Differentiation—KDR—sarcoma	2.91e-05	0.0115	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—MYOG—sarcoma	2.81e-05	0.0111	CbGpPWpGaD
Carbamazepine—SCN5A—Cardiac Progenitor Differentiation—KIT—sarcoma	2.68e-05	0.0106	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—CREB1—sarcoma	2.54e-05	0.0101	CbGpPWpGaD
Carbamazepine—CYP2B6—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	2.36e-05	0.00936	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—EZR—sarcoma	2.32e-05	0.00918	CbGpPWpGaD
Carbamazepine—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	2.31e-05	0.00915	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—EZR—sarcoma	2.13e-05	0.00843	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—EZR—sarcoma	2.02e-05	0.00801	CbGpPWpGaD
Carbamazepine—CYP2C19—Melatonin metabolism and effects—FOXO1—sarcoma	1.93e-05	0.00765	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—PTPRC—sarcoma	1.91e-05	0.00758	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—MYOG—sarcoma	1.9e-05	0.00754	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—MYOD1—sarcoma	1.89e-05	0.00748	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	1.87e-05	0.00742	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—PLCG1—sarcoma	1.87e-05	0.00742	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—JUN—sarcoma	1.83e-05	0.00725	CbGpPWpGaD
Carbamazepine—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	1.79e-05	0.00707	CbGpPWpGaD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	1.78e-05	0.00704	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—PTPRC—sarcoma	1.76e-05	0.00697	CbGpPWpGaD
Carbamazepine—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	1.74e-05	0.0069	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—MYOD1—sarcoma	1.74e-05	0.00687	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—PLCG1—sarcoma	1.72e-05	0.00682	CbGpPWpGaD
Carbamazepine—SCN9A—L1CAM interactions—SRC—sarcoma	1.64e-05	0.00652	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—SRC—sarcoma	1.64e-05	0.0065	CbGpPWpGaD
Carbamazepine—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	1.63e-05	0.00645	CbGpPWpGaD
Carbamazepine—SCN4A—L1CAM interactions—SRC—sarcoma	1.51e-05	0.00599	CbGpPWpGaD
Carbamazepine—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	1.51e-05	0.00596	CbGpPWpGaD
Carbamazepine—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	1.49e-05	0.00591	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—EZR—sarcoma	1.44e-05	0.00572	CbGpPWpGaD
Carbamazepine—SCN9A—L1CAM interactions—EGFR—sarcoma	1.44e-05	0.00571	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—EGFR—sarcoma	1.44e-05	0.0057	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—PTPRC—sarcoma	1.37e-05	0.00541	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—KRAS—sarcoma	1.36e-05	0.00538	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—PLCG1—sarcoma	1.34e-05	0.00529	CbGpPWpGaD
Carbamazepine—SCN4A—L1CAM interactions—EGFR—sarcoma	1.32e-05	0.00525	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	1.32e-05	0.00524	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—PTPRC—sarcoma	1.25e-05	0.00497	CbGpPWpGaD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	1.24e-05	0.0049	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—PLCG1—sarcoma	1.23e-05	0.00486	CbGpPWpGaD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	1.22e-05	0.00483	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—PTPRC—sarcoma	1.19e-05	0.00472	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—MYOD1—sarcoma	1.18e-05	0.00466	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—PLCG1—sarcoma	1.17e-05	0.00462	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—HRAS—sarcoma	1.16e-05	0.00458	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—KDR—sarcoma	1.1e-05	0.00435	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—CREB1—sarcoma	1.08e-05	0.00427	CbGpPWpGaD
Carbamazepine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	1.07e-05	0.00425	CbGpPWpGaD
Carbamazepine—SCN5A—L1CAM interactions—SRC—sarcoma	1.02e-05	0.00406	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TLE1—sarcoma	1.02e-05	0.00403	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—KDR—sarcoma	1.01e-05	0.004	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—CREB1—sarcoma	9.63e-06	0.00382	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—FOXO1—sarcoma	9.48e-06	0.00376	CbGpPWpGaD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	9.44e-06	0.00374	CbGpPWpGaD
Carbamazepine—SCN5A—L1CAM interactions—EGFR—sarcoma	8.98e-06	0.00356	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—MMP2—sarcoma	8.97e-06	0.00355	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—CREB1—sarcoma	8.85e-06	0.00351	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—FOXO1—sarcoma	8.71e-06	0.00345	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—VEGFC—sarcoma	8.58e-06	0.0034	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—PTPRC—sarcoma	8.5e-06	0.00337	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—PLCG1—sarcoma	8.32e-06	0.0033	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—PDGFRA—sarcoma	8.31e-06	0.00329	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—MMP2—sarcoma	8.24e-06	0.00327	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—KDR—sarcoma	7.84e-06	0.00311	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—JUN—sarcoma	7.75e-06	0.00307	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	7.73e-06	0.00306	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—sarcoma	7.69e-06	0.00305	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—KDR—sarcoma	7.2e-06	0.00285	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	7.08e-06	0.00281	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—CREB1—sarcoma	6.87e-06	0.00272	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—FLT1—sarcoma	6.86e-06	0.00272	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—KDR—sarcoma	6.84e-06	0.00271	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—VEGFA—sarcoma	6.77e-06	0.00268	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PLCG1—sarcoma	6.74e-06	0.00267	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CXCR4—sarcoma	6.47e-06	0.00257	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—ATF1—sarcoma	6.4e-06	0.00254	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—MMP2—sarcoma	6.4e-06	0.00254	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—CREB1—sarcoma	6.32e-06	0.0025	CbGpPWpGaD
Carbamazepine—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	6.24e-06	0.00247	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—SRC—sarcoma	6.21e-06	0.00246	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—VEGFA—sarcoma	6.05e-06	0.0024	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—CREB1—sarcoma	6e-06	0.00238	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—NRAS—sarcoma	5.98e-06	0.00237	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—FOXO1—sarcoma	5.9e-06	0.00234	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—MMP2—sarcoma	5.88e-06	0.00233	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—SRC—sarcoma	5.71e-06	0.00226	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—MMP2—sarcoma	5.59e-06	0.00221	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	5.58e-06	0.00221	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—VEGFA—sarcoma	5.56e-06	0.0022	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—NRAS—sarcoma	5.49e-06	0.00218	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—EGFR—sarcoma	5.45e-06	0.00216	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	5.43e-06	0.00215	CbGpPWpGaD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	5.2e-06	0.00206	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—KRAS—sarcoma	5.15e-06	0.00204	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	5.09e-06	0.00202	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IGF1R—sarcoma	5.02e-06	0.00199	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—EGFR—sarcoma	5.01e-06	0.00198	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—CTNNB1—sarcoma	4.91e-06	0.00194	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—KDR—sarcoma	4.88e-06	0.00194	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	4.87e-06	0.00193	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	4.87e-06	0.00193	CbGpPWpGaD
Carbamazepine—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	4.82e-06	0.00191	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—FOXO1—sarcoma	4.78e-06	0.00189	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PDGFRB—sarcoma	4.77e-06	0.00189	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	4.74e-06	0.00188	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—KRAS—sarcoma	4.73e-06	0.00187	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PDGFRA—sarcoma	4.7e-06	0.00186	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	4.68e-06	0.00186	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—IL2—sarcoma	4.53e-06	0.0018	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—CTNNB1—sarcoma	4.51e-06	0.00179	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	4.45e-06	0.00176	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—SRC—sarcoma	4.43e-06	0.00176	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—HRAS—sarcoma	4.37e-06	0.00173	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	4.36e-06	0.00173	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—VEGFA—sarcoma	4.32e-06	0.00171	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—CREB1—sarcoma	4.28e-06	0.0017	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	4.27e-06	0.00169	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	4.27e-06	0.00169	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—NRAS—sarcoma	4.27e-06	0.00169	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	4.1e-06	0.00163	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—SRC—sarcoma	4.08e-06	0.00161	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	4.03e-06	0.0016	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—HRAS—sarcoma	4.02e-06	0.00159	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—MMP2—sarcoma	3.99e-06	0.00158	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—VEGFA—sarcoma	3.97e-06	0.00157	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—KDR—sarcoma	3.95e-06	0.00157	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—NRAS—sarcoma	3.92e-06	0.00155	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—EGFR—sarcoma	3.89e-06	0.00154	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—SRC—sarcoma	3.87e-06	0.00153	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—VEGFA—sarcoma	3.85e-06	0.00153	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—VEGFA—sarcoma	3.77e-06	0.00149	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—NRAS—sarcoma	3.72e-06	0.00148	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—KRAS—sarcoma	3.67e-06	0.00145	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—KIT—sarcoma	3.64e-06	0.00144	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—EGFR—sarcoma	3.57e-06	0.00142	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CREB1—sarcoma	3.47e-06	0.00137	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ENO2—sarcoma	3.46e-06	0.00137	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—HBA1—sarcoma	3.44e-06	0.00136	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	3.43e-06	0.00136	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—EGFR—sarcoma	3.39e-06	0.00134	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—KRAS—sarcoma	3.37e-06	0.00134	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—KRAS—sarcoma	3.21e-06	0.00127	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—HRAS—sarcoma	3.12e-06	0.00124	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—CTNNB1—sarcoma	3.06e-06	0.00121	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	3.03e-06	0.0012	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PLCG1—sarcoma	2.93e-06	0.00116	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MDM2—sarcoma	2.87e-06	0.00114	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—HRAS—sarcoma	2.87e-06	0.00114	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—SRC—sarcoma	2.76e-06	0.00109	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—HRAS—sarcoma	2.72e-06	0.00108	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—VEGFA—sarcoma	2.69e-06	0.00107	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—NRAS—sarcoma	2.66e-06	0.00105	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IL2—sarcoma	2.56e-06	0.00102	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.5e-06	0.000992	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CCND1—sarcoma	2.5e-06	0.00099	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—JUN—sarcoma	2.49e-06	0.000988	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CTNNB1—sarcoma	2.47e-06	0.000981	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—EGFR—sarcoma	2.42e-06	0.000959	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ENO2—sarcoma	2.36e-06	0.000936	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—HBA1—sarcoma	2.35e-06	0.000931	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—KRAS—sarcoma	2.29e-06	0.000906	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—SRC—sarcoma	2.24e-06	0.000886	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	2.18e-06	0.000864	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—VEGFA—sarcoma	2.18e-06	0.000863	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	2.18e-06	0.000863	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	2.16e-06	0.000856	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—NRAS—sarcoma	2.15e-06	0.000853	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PLCG1—sarcoma	2.01e-06	0.000795	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MYC—sarcoma	2e-06	0.000794	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—EGFR—sarcoma	1.96e-06	0.000777	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.95e-06	0.000774	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—HRAS—sarcoma	1.94e-06	0.00077	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.9e-06	0.000754	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—KRAS—sarcoma	1.85e-06	0.000734	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.75e-06	0.000693	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ENO2—sarcoma	1.75e-06	0.000693	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—HBA1—sarcoma	1.74e-06	0.000688	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.71e-06	0.000678	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ENO2—sarcoma	1.71e-06	0.000677	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—HBA1—sarcoma	1.7e-06	0.000673	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—sarcoma	1.65e-06	0.000652	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.62e-06	0.000641	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HRAS—sarcoma	1.57e-06	0.000624	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PLCG1—sarcoma	1.48e-06	0.000588	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ENO2—sarcoma	1.48e-06	0.000586	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HBA1—sarcoma	1.47e-06	0.000583	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PLCG1—sarcoma	1.45e-06	0.000574	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.44e-06	0.000569	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ENO2—sarcoma	1.32e-06	0.000523	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HBA1—sarcoma	1.31e-06	0.00052	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ENO2—sarcoma	1.29e-06	0.000511	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HBA1—sarcoma	1.28e-06	0.000508	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PLCG1—sarcoma	1.26e-06	0.000497	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ENO2—sarcoma	1.2e-06	0.000477	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HBA1—sarcoma	1.2e-06	0.000474	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PLCG1—sarcoma	1.12e-06	0.000444	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PLCG1—sarcoma	1.09e-06	0.000433	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ENO2—sarcoma	1.03e-06	0.000408	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HBA1—sarcoma	1.02e-06	0.000405	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PLCG1—sarcoma	1.02e-06	0.000405	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PLCG1—sarcoma	8.73e-07	0.000346	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ENO2—sarcoma	7.94e-07	0.000315	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HBA1—sarcoma	7.89e-07	0.000313	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PLCG1—sarcoma	6.74e-07	0.000267	CbGpPWpGaD
